Faculty

Dr. Zaril Harza Zakaria is a senior regulatory pharmacist with more than 20 years of expertise in clinical trial evaluation and pharmaceutical policy. He currently leads the Investigational Product Evaluation and Safety Section at the National Pharmaceutical Regulatory Agency (NPRA), where he oversees the safety and evaluation of research products.  

An international authority in First-in-Human (FIH) frameworks, Dr. Zakaria has served as a WHO Expert and chaired the ASEAN Joint Sectoral Committee for Bio-Equivalence. During the COVID-19 pandemic, he played a vital role in vaccine candidate selection and national reporting.  

Dr. Zakaria earned his Ph.D. in Pharmacokinetics from Aston University and a Master’s in Clinical Research from Cranfield University, UK. His technical leadership is complemented by numerous publications in peer-reviewed journals and his ongoing work in drafting national clinical trial regulations.